Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The Food and Drug Administration (FDA) last week granted the first approval for UK pharma major AstraZeneca’s Datroway ...

AstraZeneca and its biologics research arm MedImmune have signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ... including significant investments from AstraZeneca and Merck. Although their vaccine candidates remained in early ...

The mRNA jabs, such as Pfizer and Moderna, have also been linked to increases in heart problems. Many countries across Europe halted the AstraZeneca rollout in 2020 after noticing a rise in ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

The Government anticipated a £1.7 billion bill for injuries caused by the coronavirus vaccine, the Covid Inquiry has heard.

On Monday, AstraZeneca plc (NASDAQ ... Under the terms of the agree China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the ...

Whitehall ‘group think’ and inter-departmental rows slammed by vaccine tsar - Dame Kate Bingham was commissioned by the previous government to help the UK secure vaccines during the pandemic.